Linked Life Data

11455218

Source:http://linkedlifedata.com/resource/pubmed/id/11455218

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-7-16
pubmed:abstractText
Symptomatic brain metastases occur in approximately 10-15% of patients suffering from breast cancer and are linked to a clear deterioration of the patient's condition. Although radiotherapy is recommended as a primary therapy, the optimal management remains controversial. To evaluate the role of topotecan as a primary chemotherapy for brain metastases, we performed a pilot study in patients with metastatic breast cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0378-584X
pubmed:author
pubmed:copyrightInfo
Copyright 2001 S. Karger GmbH, Freiburg
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
256-60
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
Topotecan chemotherapy in patients with breast cancer and brain metastases: results of a pilot study.
pubmed:affiliation
Abteilung für Gynäkologie, Zentrum für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Essen, Hufelandstrasse 55, D-45122 Essen, Germany. carsten.oberhoff@uni-essen.de
pubmed:publicationType
Journal Article, Clinical Trial, Multicenter Study, Clinical Trial, Phase II